# Marstacimab (Genetical Recombination) S.C. Injection 150mg Pen (ヒムペブジ皮下注１５０ｍｇペン)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6343462G1026). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6343462G1026
- **Product name (Japanese):** ヒムペブジ皮下注１５０ｍｇペン
- **English title:** Marstacimab (Genetical Recombination) S.C. Injection 150mg Pen
- **Active ingredient:** マルスタシマブ（遺伝子組換え）
- **Active ingredient (INN):** Marstacimab (Genetical Recombination)
- **Strength / unit:** １５０ｍｇ１ｍＬ１キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 63 Biological products (生物学的製剤) › 634 Blood products (血液製剤類)
- **Manufacturer:** Pfizer Japan (ファイザー)
- **NHI price (reference only):** JPY 883108 per １５０ｍｇ１ｍＬ１キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6343462G1026
- **JSON:** https://www.nifujipharma.com/api/drugs/6343462G1026

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Marstacimab%20(Genetical%20Recombination)%20S.C.%20Injection%20150mg%20Pen%20(%E3%83%92%E3%83%A0%E3%83%9A%E3%83%96%E3%82%B8%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%91%EF%BC%95%EF%BC%90%EF%BD%8D%EF%BD%87%E3%83%9A%E3%83%B3)%20%2F%20YJ%206343462G1026#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.
